The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital

Objetive: to evaluate the adherence of health professionals to interventions by the clinical pharmacist service in the prevention of venous thromboembolism in a teaching hospital. Methods: This is a retrospective study in which, through data collection and analysis statistics (considering p <0.0...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Julia S. GOMES, Rita C. CORNÉLIO, Soraida S. MIGUEL
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2021
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/17ca924828fd4684bb74df91fb16dc31
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:17ca924828fd4684bb74df91fb16dc31
record_format	dspace
spelling	oai:doaj.org-article:17ca924828fd4684bb74df91fb16dc312021-11-28T02:43:34ZThe Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital10.30968/rbfhss.2021.121.05642179-59242316-7750https://doaj.org/article/17ca924828fd4684bb74df91fb16dc312021-03-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/564https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objetive: to evaluate the adherence of health professionals to interventions by the clinical pharmacist service in the prevention of venous thromboembolism in a teaching hospital. Methods: This is a retrospective study in which, through data collection and analysis statistics (considering p <0.05 as the level of significance), pharmaceutical therapies related to drug prescription related to prophylaxis of venous thromboembolism (following the protocol in force at the institution) for patients admitted to a teaching hospital in Minas Gerais from December 2019 to August 2020.. The level of acceptance of clinical pharmacy interventions regarding the need to prescribe prophylactic anticoagulants, change in anticoagulation dosage, prescription of two or more anticoagulants and the lack of risk classification was evaluated for the development of venous thromboembolism for inpatients. Results: in the nine-month period, 62 pharmaceutical interventions were performed before the clinical staff, with 82.25% adherence: need for prescription of anticoagulants (82.75%); change in anticoagulation dosage (80%) and prescription of two or more anticoagulants (100%). In the same period, 2070 interventions (100%) with the nursing team were identified regarding the lack of risk classification for the development of venous thromboembolism for patients admitted via the RM Saude system. Conclusion: the evaluation allowed to identify the importance of the clinical pharmacist in the prevention of thromboembolic events for patients admitted to a hospital. Julia S. GOMESRita C. CORNÉLIOSoraida S. MIGUELSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 12, Iss 1 (2021)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Julia S. GOMES Rita C. CORNÉLIO Soraida S. MIGUEL The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital
description	Objetive: to evaluate the adherence of health professionals to interventions by the clinical pharmacist service in the prevention of venous thromboembolism in a teaching hospital. Methods: This is a retrospective study in which, through data collection and analysis statistics (considering p <0.05 as the level of significance), pharmaceutical therapies related to drug prescription related to prophylaxis of venous thromboembolism (following the protocol in force at the institution) for patients admitted to a teaching hospital in Minas Gerais from December 2019 to August 2020.. The level of acceptance of clinical pharmacy interventions regarding the need to prescribe prophylactic anticoagulants, change in anticoagulation dosage, prescription of two or more anticoagulants and the lack of risk classification was evaluated for the development of venous thromboembolism for inpatients. Results: in the nine-month period, 62 pharmaceutical interventions were performed before the clinical staff, with 82.25% adherence: need for prescription of anticoagulants (82.75%); change in anticoagulation dosage (80%) and prescription of two or more anticoagulants (100%). In the same period, 2070 interventions (100%) with the nursing team were identified regarding the lack of risk classification for the development of venous thromboembolism for patients admitted via the RM Saude system. Conclusion: the evaluation allowed to identify the importance of the clinical pharmacist in the prevention of thromboembolic events for patients admitted to a hospital.
format	article
author	Julia S. GOMES Rita C. CORNÉLIO Soraida S. MIGUEL
author_facet	Julia S. GOMES Rita C. CORNÉLIO Soraida S. MIGUEL
author_sort	Julia S. GOMES
title	The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital
title_short	The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital
title_full	The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital
title_fullStr	The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital
title_full_unstemmed	The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital
title_sort	clinical pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2021
url	https://doaj.org/article/17ca924828fd4684bb74df91fb16dc31
work_keys_str_mv	AT juliasgomes theclinicalpharmacistassessmentintheprophylaxisofvenousthromboembolisminauniversityhospital AT ritaccornelio theclinicalpharmacistassessmentintheprophylaxisofvenousthromboembolisminauniversityhospital AT soraidasmiguel theclinicalpharmacistassessmentintheprophylaxisofvenousthromboembolisminauniversityhospital AT juliasgomes clinicalpharmacistassessmentintheprophylaxisofvenousthromboembolisminauniversityhospital AT ritaccornelio clinicalpharmacistassessmentintheprophylaxisofvenousthromboembolisminauniversityhospital AT soraidasmiguel clinicalpharmacistassessmentintheprophylaxisofvenousthromboembolisminauniversityhospital
_version_	1718408423115063296

The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital

Ejemplares similares